Effect of angiotensin-converting enzyme inhibitor therapy on 30-day outcome in patient > or = 65 years of age with chronic congestive heart failure.
Patients discharged from the hospital on an angiotensin-converting enzyme inhibitor had a significant decrease in 30-day death or readmission (by 30% in 1,195 unselected Medicare patients hospitalized with congestive heart failure). Other independent predictors of poor outcome determined by multivariate analysis included history of congestive heart failure, male gender, increased number of comorbidities, higher serum blood urea nitrogen, and lower serum sodium.
Sueta
C A
CA
Medical Review of North Carolina, Raleigh 27627, USA.
Schenck
A
A
Chowdhury
M
M
Hall
R
R
Simpson
R J
RJ
D017677:Age Distribution; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001806:Blood Urea Nitrogen; D002908:Chronic Disease; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality* / Q000503:physiopathology; D006801:Humans; D008297:Male; D009657:North Carolina / Q000453:epidemiology; D010359:Patient Readmission / Q000706:statistics & numerical data; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012964:Sodium / Q000097:blood; D016019:Survival Analysis; D016896:Treatment Outcome; D016277:Ventricular Function, Left
D000806:Angiotensin-Converting Enzyme Inhibitors; D012964:Sodium